US · Healthcare · Medical Care Facilities
EPS came in at 0.64 against a street estimate of 0.53 — a beat of 20.8%.
Analysts rate Fresenius Medical Care Corporation a hold (1 buy, 3 hold, 3 sell out of 7) with an average price target of $23.54.
| Fund | Stake |
|---|---|
| Pzena Investment Management, LLC | 2.82% |
| Morgan Stanley - Brokerage Accounts | 0.82% |
| Dodge & Cox | 0.72% |
| Fiduciary Management, Inc. of Milwaukee | 0.55% |
| Brandes Investment Partners & Co | 0.36% |
| Millennium Management LLC | 0.30% |
| Todd Asset Management | 0.25% |
| The Goldman Sachs Group Inc | 0.17% |
| Document | Date |
|---|---|
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • The document is an unaudited interim report for the three and nine months ended September 30, 2026, compared with the same periods | 2026-11-03 |
| Quarterly results (6-K) · Q3 2026 HEADLINE NUMBERS • Q3 2026 revenue rose 1% year over year to EUR 4,937 million, but declined 1% at constant currency. • Q3 operating income fell 19% | 2026-11-03 |
| Current report (6-K) · Q4 2026 OTHER NOTABLE POINTS • Fresenius Medical Care AG filed a Form 6-K with the U.S. Securities and Exchange Commission for October 2026. • The filing in | 2026-10-07 |
| Current report (6-K) · Q3 2026 OTHER NOTABLE POINTS • Fresenius Medical Care AG filed a Form 6-K with the U.S. Securities and Exchange Commission for September 2026. • The filing | 2026-09-25 |
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • A multinational real-world study associated hemodiafiltration (HDF) with a 28% lower relative risk of all-cause mortality versus c | 2026-08-27 |
| Current report (6-K) · Q2 2026 HEADLINE NUMBERS • The document is Fresenius Medical Care AG’s unaudited interim report for the three and six months ended June 30, 2026, compared wi | 2026-08-04 |
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • The document is a Form 6-K filed by Fresenius Medical Care AG on August 3, 2026. • It covers the month of August 2026 and include | 2026-08-03 |
| Annual report FY2025 (20-F) HEADLINE NUMBERS • Fiscal year covered: December 31, 2025; reporting under International Financial Reporting Standards issued by the International Ac | 2026-02-24 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.87 / share ex-date May 22, 2026 · pay Jun 8, 2026 | 2026-05-22 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Fresenius Medical Care Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.